{
    "code": "01048561",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01048561",
    "time": "2020-02-21 04:03:08",
    "許可證字號": "衛署藥製字第048561號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "111\/01\/29",
    "發證日期": "96\/01\/29",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00104856102",
    "中文品名": "優鉑廷靜脈注射液5毫克\/毫升",
    "英文品名": "Olatin I.V. Injection 5mg\/ml",
    "適應症": "和5-fluorouracil(5-FU)及folinic acid(FA)併用，作為:\r\n－第三期結腸癌(Duke's C)原發腫瘤完全切除手術後的輔助療法。\r\n－治療轉移性結腸直腸癌。\r\n Olatin和Capecitabine併用可用於局部晚期及復發\/轉移性胃癌之治療。",
    "劑型": "270注射劑",
    "包裝": "10、20毫升玻璃小瓶裝 100支以下盒裝",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "01國　產 09委託製造 24監視期滿學名藥",
        "申請商名稱": "0901301200  美時化學製藥股份有限公司",
        "申請商地址": "台北市信義區松仁路277號17樓",
        "主製造廠": ""
    },
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1012001600",
            "成分名稱": "OXALIPLATIN",
            "含量描述": "",
            "含量": "5.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "優鉑廷靜脈注射液_仿單-105-11-20.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01048561&Seq=007&Type=9"
        },
        {
            "title": "優鉑廷靜脈注射液_標籤-105-11-20.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01048561&Seq=007&Type=8"
        }
    ]
}